Clinical Trials Browser

Phase EARLY_PHASE1 × Esophageal Squamous Cell Carcinoma × tislelizumab × Clear all

NCT06690476 2024-11-15

Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell Carcinoma

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma